Janney Montgomery Scott LLC reduced its position in National Health Investors, Inc. (NYSE:NHI – Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 20,814 shares of the real estate investment trust’s stock after selling 183 shares during the period. Janney Montgomery Scott LLC’s holdings in National Health Investors were worth $1,442,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Zimmer Partners LP bought a new position in National Health Investors in the 3rd quarter worth approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of National Health Investors by 332.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock worth $20,370,000 after acquiring an additional 186,238 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of National Health Investors by 17.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after acquiring an additional 123,596 shares during the period. Waterfront Capital Partners LLC purchased a new position in shares of National Health Investors in the third quarter valued at $10,097,000. Finally, Easterly Investment Partners LLC bought a new stake in shares of National Health Investors during the 3rd quarter valued at $5,632,000. 62.51% of the stock is owned by hedge funds and other institutional investors.
National Health Investors Stock Up 0.9 %
NHI stock opened at $68.71 on Tuesday. The company’s 50 day moving average is $70.65 and its 200 day moving average is $75.74. The stock has a market cap of $3.12 billion, a price-to-earnings ratio of 23.61, a price-to-earnings-growth ratio of 4.32 and a beta of 1.06. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13.
Analyst Upgrades and Downgrades
Several research analysts have commented on the company. Truist Financial cut their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $76.60.
Get Our Latest Stock Report on NHI
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
- Five stocks we like better than National Health Investors
- Insider Trading – What You Need to Know
- How to Invest in Small Cap Stocks
- How to Profit From Growth Investing
- These Are the Dividend Stocks Insiders Bought in January
- What is Forex and How Does it Work?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.